Clinafloxacin is an investigational fluoroquinolone antibiotic compound. Its clinical development has been limited due to the risk of serious side effects, despite its promising antibacterial activity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 105956-97-6
Besifloxacin hydrochloride
pharmaceutical raw material
Clodronic acid
pharmaceutical raw material
Aminolevulinic acid
pharmaceutical raw material
Rufloxacin hydrochloride
pharmaceutical raw material
(S)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole
pharmaceutical raw material
7-(3-aminopyrrolidin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
QGPKADBNRMWEQR-UHFFFAOYSA-N
C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)Cl)N4CCC(C4)N)F)C(=O)O